Jupiter Topco LLC Takes $3.15 Million Position in Smith & Nephew SNATS, Inc. $SNN

Jupiter Topco LLC acquired a new position in Smith & Nephew SNATS, Inc. (NYSE:SNN) during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 50,179 shares of the medical equipment provider’s stock, valued at approximately $3,147,000.

Several other large investors have also made changes to their positions in the business. Mitsubishi UFJ Asset Management Co. Ltd. bought a new position in Smith & Nephew SNATS in the 2nd quarter worth approximately $13,812,000. Grandfield & Dodd LLC acquired a new position in shares of Smith & Nephew SNATS during the second quarter worth approximately $13,192,000. Teachers Retirement System of The State of Kentucky boosted its position in shares of Smith & Nephew SNATS by 51.0% in the first quarter. Teachers Retirement System of The State of Kentucky now owns 905,100 shares of the medical equipment provider’s stock valued at $28,764,000 after acquiring an additional 305,600 shares during the period. BlackRock Inc. bought a new stake in shares of Smith & Nephew SNATS in the second quarter valued at approximately $505,323,000. Finally, Deutsche Bank AG bought a new stake in shares of Smith & Nephew SNATS in the second quarter valued at approximately $33,563,000. Institutional investors and hedge funds own 25.64% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on SNN. BTIG Research began coverage on shares of Smith & Nephew SNATS in a research report on Monday. They set a “neutral” rating on the stock. Zacks Research cut shares of Smith & Nephew SNATS from a “hold” rating to a “strong sell” rating in a research note on Friday, August 7th. Canaccord Genuity Group reduced their price target on shares of Smith & Nephew SNATS from $32.00 to $30.00 and set a “hold” rating for the company in a report on Monday, May 11th. The Goldman Sachs Group restated a “buy” rating on shares of Smith & Nephew SNATS in a research report on Monday, May 25th. Finally, Sanford C. Bernstein set a $31.85 price objective on shares of Smith & Nephew SNATS in a report on Monday, May 11th. One investment analyst has rated the stock with a Buy rating, eight have given a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Reduce” and a consensus price target of $30.93.

Smith & Nephew SNATS Trading Down 1.0%

Smith & Nephew SNATS stock opened at $28.68 on Thursday. The business has a 50 day moving average price of $30.17 and a two-hundred day moving average price of $31.52. The company has a quick ratio of 1.11, a current ratio of 2.14 and a debt-to-equity ratio of 0.62. Smith & Nephew SNATS, Inc. has a 12 month low of $28.56 and a 12 month high of $38.79.

Smith & Nephew SNATS Announces Dividend

The company also recently disclosed a dividend, which will be paid on Friday, November 6th. Stockholders of record on Friday, October 2nd will be given a dividend of $0.312 per share. The ex-dividend date is Friday, October 2nd. This represents a dividend yield of 205.0%.

Smith & Nephew SNATS Company Profile

Smith & Nephew plc is a global medical technology company specializing in the design, development and manufacture of advanced surgical devices, orthopaedic reconstruction implants, trauma and extremities products, sports medicine solutions and wound care therapies. Founded in 1856 in Hull, United Kingdom, the company has grown through both organic innovation and strategic acquisitions to offer a broad portfolio that addresses patient needs across joint replacement, minimally invasive surgery and wound healing.

In its orthopaedics business, Smith & Nephew provides hip and knee replacement systems, modular joint revision implants and biologic solutions for bone repair.